EMV Capital PLC (EMVC) RNS Announcements | Ticker

⌘K

EMV Capital PLC (EMVC) RNS Announcements | Ticker | Ticker

Showing 151–173 of 173 announcements

Showing 151–173 of 173 announcements

EMV Capital PLC RNS

EMV Capital PLC RNS

Date	Time	Date	TitleTitle (filtered)
29/12/21	08:47:53	29 Dec 2021	Issue of Equity	Issue of Equity
21/12/21	13:59:13	21 Dec 2021	TR-1: Form for notification of major holdings	TR-1: Form for notification of major holdings
21/12/21	07:00:04	21 Dec 2021	Q-Bot Investment and Share Acquisition	Q-Bot Investment and Share Acquisition
20/12/21	07:00:06	20 Dec 2021	Acquisition of majority stake in Cetromed	Acquisition of majority stake in Cetromed
13/12/21	07:00:07	13 Dec 2021	Martlet Capital Update	Martlet Capital Update
06/12/21	14:53:12	6 Dec 2021	PDS Phase 2 Clinical Trial Update	PDS Phase 2 Clinical Trial Update
26/11/21	07:00:07	26 Nov 2021	$1million investment in portfolio company, EpiBone	$1million investment in portfolio company, EpiBone
10/11/21	13:58:01	10 Nov 2021	PDS Reports Q3 2021 Results & Business Update	PDS Reports Q3 2021 Results & Business Update
04/11/21	07:00:05	4 Nov 2021	Sofant Signs EUR7.3m ESA Contract	Sofant Signs EUR7.3m ESA Contract
01/11/21	14:16:24	1 Nov 2021	PDS to License Novel Proteins for Flu Vaccine	PDS to License Novel Proteins for Flu Vaccine
26/10/21	07:00:05	26 Oct 2021	EMV Capital Participates in £843k Sofant Funding	EMV Capital Participates in £843k Sofant Funding
22/10/21	11:18:59	22 Oct 2021	ProAxsis announces the approval of a key US patent	ProAxsis announces the approval of a key US patent
22/10/21	09:04:11	22 Oct 2021	Holding(s) in Company	Holding(s) in Company
21/10/21	16:40:37	21 Oct 2021	Second Price Monitoring Extn	Second Price Monitoring Extn
21/10/21	16:35:35	21 Oct 2021	Price Monitoring Extension	Price Monitoring Extension
21/10/21	14:17:10	21 Oct 2021	PDS Phase 2 Clinical Trial Update	PDS Phase 2 Clinical Trial Update
05/10/21	07:00:08	5 Oct 2021	PDS Phase 2 Clinical Trial Update	PDS Phase 2 Clinical Trial Update
04/10/21	07:00:08	4 Oct 2021	Investor Presentations	Investor Presentations
30/09/21	10:22:30	30 Sept 2021	Holding(s) in Company	Holding(s) in Company
29/09/21	07:00:10	29 Sept 2021	Grant of Options to Directors	Grant of Options to Directors
29/09/21	07:00:07	29 Sept 2021	Interim Results	Interim Results
20/09/21	07:00:08	20 Sept 2021	Notice of Results and Analyst Briefing	Notice of Results and Analyst Briefing
16/09/21	07:00:03	16 Sept 2021	Investment in Martlet Capital Limited	Investment in Martlet Capital Limited